SHINGRIX

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland

Active ingredients

The drug SHINGRIX contains one active pharmaceutical ingredient (API):

1 Human varicela zoster immunoglobulin
UNII COB9FF6I46 - RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN

Human varicella zoster immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against varicella-zoster virus. It is used for prophylaxis against varicella zoster virus (VZV) infection.

Read about Human varicela zoster immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SHINGRIX Powder for suspension for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BK03 J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BK Varicella zoster vaccines
Discover more medicines within J07BK03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02468425
Country: EE Ravimiamet Identifier(s): 1767315, 1767326
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1181272001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 176947
Country: FR Base de données publique des médicaments Identifier(s): 62887096
Country: HK Department of Health Drug Office Identifier(s): 66840
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9249
Country: IT Agenzia del Farmaco Identifier(s): 046337010, 046337022
Country: JP 医薬品医療機器総合機構 Identifier(s): 631341BE1028
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1085276, 1085277
Country: NL Z-Index G-Standaard, PRK Identifier(s): 202843
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 20173
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100402280

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.